THE DOPE DOULA
THE DOPE DOULA
  • HOME
  • ARTIST SEARCH
  • RESOURCES
    • DRUG DICTIONARY
    • FOR PARENTS / CAREGIVERS
    • GENDER IDENTITY
    • NAVIGATING PSYCHEDELICS
    • SOCIAL JUSTICE - RACE
    • STIGMA
    • THE WAR ON DRUGS
    • TOOLS
    • 2C CHEMICALS | 2C-B
    • 5-MEO-DMT
    • ALCOHOL
    • BENZODIAZEPINES | XANAX
    • CAT | KAT | METHCATHINONE
    • CANNABIS | WEED | DAGGA
    • COCAINE | COKE | CHARLIE
    • DMT | CHANGA
    • GHB | GBL | LIQUID E
    • HEROIN | FENTANYL| NYAOPE
    • IBOGAINE | IBOGA | WOOD
    • KAMBO
    • KETAMIN | KET | SPECIAL K
    • LSA | DATURA | SALVIA
    • LSD | ACID | TRIPS
    • MANDRAX | BUTTONS | LUDES
    • MDMA | MANDY | PILLS
    • MUSHROOMS | SHROOMS
    • SAN PEDRO | PEYOTE
    • METH | CRYSTAL | TIK
    • OVERDOSE
  • CONTACT
  • BLOG
  • More
    • HOME
    • ARTIST SEARCH
    • RESOURCES
      • DRUG DICTIONARY
      • FOR PARENTS / CAREGIVERS
      • GENDER IDENTITY
      • NAVIGATING PSYCHEDELICS
      • SOCIAL JUSTICE - RACE
      • STIGMA
      • THE WAR ON DRUGS
      • TOOLS
      • 2C CHEMICALS | 2C-B
      • 5-MEO-DMT
      • ALCOHOL
      • BENZODIAZEPINES | XANAX
      • CAT | KAT | METHCATHINONE
      • CANNABIS | WEED | DAGGA
      • COCAINE | COKE | CHARLIE
      • DMT | CHANGA
      • GHB | GBL | LIQUID E
      • HEROIN | FENTANYL| NYAOPE
      • IBOGAINE | IBOGA | WOOD
      • KAMBO
      • KETAMIN | KET | SPECIAL K
      • LSA | DATURA | SALVIA
      • LSD | ACID | TRIPS
      • MANDRAX | BUTTONS | LUDES
      • MDMA | MANDY | PILLS
      • MUSHROOMS | SHROOMS
      • SAN PEDRO | PEYOTE
      • METH | CRYSTAL | TIK
      • OVERDOSE
    • CONTACT
    • BLOG
  • HOME
  • ARTIST SEARCH
  • RESOURCES
    • DRUG DICTIONARY
    • FOR PARENTS / CAREGIVERS
    • GENDER IDENTITY
    • NAVIGATING PSYCHEDELICS
    • SOCIAL JUSTICE - RACE
    • STIGMA
    • THE WAR ON DRUGS
    • TOOLS
    • 2C CHEMICALS | 2C-B
    • 5-MEO-DMT
    • ALCOHOL
    • BENZODIAZEPINES | XANAX
    • CAT | KAT | METHCATHINONE
    • CANNABIS | WEED | DAGGA
    • COCAINE | COKE | CHARLIE
    • DMT | CHANGA
    • GHB | GBL | LIQUID E
    • HEROIN | FENTANYL| NYAOPE
    • IBOGAINE | IBOGA | WOOD
    • KAMBO
    • KETAMIN | KET | SPECIAL K
    • LSA | DATURA | SALVIA
    • LSD | ACID | TRIPS
    • MANDRAX | BUTTONS | LUDES
    • MDMA | MANDY | PILLS
    • MUSHROOMS | SHROOMS
    • SAN PEDRO | PEYOTE
    • METH | CRYSTAL | TIK
    • OVERDOSE
  • CONTACT
  • BLOG

IBOGAINE | IBOGA

Substance Information Sheet

Ibogaine

10-Methoxyibogamine, commonly known as ibogaine, is a naturally occurring psychedelic in the tryptamine class. It is an indole alkaloid primarily found in the plant Tabernanthe iboga, while similar alkaloids can be found in other plants from the Apocynaceae family, like Voacanga africana and Tabernaemontana undulata.

Class Membership

Psychoactive class - Psychedelic

Chemical class - Tryptamine

CRITICAL WARNING

Ibogaine can cause life-threatening heart complications.

Using ibogaine in high doses or for consecutive days is strongly discouraged. It is crucial to have a trip sitter with appropriate medical training and equipment present to ensure safety during its use.

What you should be asking

FAQs

Common Iboga Interactions:


1. Methamphetamine: Mixing ibogaine with meth or any other stimulant should be strictly avoided. Since ibogaine itself is a stimulant, combining the two can amplify their effects and significantly increase cardiac risk and liver damage. Ideally, individuals should be off all amphetamines for 7-14 days before taking ibogaine. This combination could be fatal.


2. Alcohol: Ibogaine lowers tolerance to alcohol and anecdotal evidence suggests alcohol can reduce the long-term benefits of ibogaine. Waiting 90 days after an ibogaine session before drinking alcohol is recommended for both safety and efficacy.


3. Other Psychedelics: Fatalities have reportedly occurred with ayahuasca when administered 1-2 weeks after ibogaine treatment. To be safe, it's best to wait 90 days before using other psychedelics. There's a lack of studies on psychedelic use post-ibogaine, so waiting ensures that you fully experience ibogaine's effects and remain safe.


4. Heroin: The risk of overdose is high after ibogaine because it resets opioid tolerance to a pre-dependent state and potentiates opioids. If ibogaine remains in the system, combining it with heroin greatly increases the risk of overdose. This combination is highly dangerous and should be avoided.


While ibogaine holds promise for many, it requires significant personal work in the weeks and months following use. It's crucial to thoroughly research all available options before choosing ibogaine and approach the experience with clear intentions and an aftercare plan. With more research, our understanding of ibogaine interactions will improve, helping answer common questions and enhancing safety.

IMPORTANT ibogaine safety considerations

Fatalities have been associated with the use of ibogaine; concomitant opioid use and comorbidities (eg, cardiovascular disease, depression, posttraumatic stress disorder, anxiety, stress, schizophrenia, epilepsy, or other imbalances in the autonomic nervous system) increase the risk of life-threatening complications including sudden cardiac death. The greatest concern about the known risks of taking iboga or ibogaine is that it decreases the heart rate (bradycardia) and prolongs the QT interval, a measurement of the time between the onset of the Q wave and the end of the T wave in the electrical cycle of the heart. Therefore, people with a history of myocardial infarction, murmurs, arrhythmias, heart surgeries or severe obesity should not take ibogaine. An electrocardiogram (ECG) is the absolute minimum test required, but a stress test and/or 24-hour monitoring with a Holter increases the possibility of detecting important abnormalities. The presence of a skilled physician (preferably a specialist in cardiology and emergency medicine) during the session, who monitors variations in heart rhythm and other vital signs, significantly increases the safety of this treatment.

Another risk factor is pulmonary embolism. This occurs when there are blood thrombi in the veins, such as those that can occur during prolonged immobility during aeroplane travel, car accidents, or blood-related diseases. When these clots circulate through the body during an ibogaine session, they can reach the lungs, where they can cause an embolism with the risk of suffocation. The risk of pulmonary embolism can be reduced by doing sports or exercise after long, sedentary trips and by avoiding initiation of treatment immediately after arrival at the destined treatment location. People with bleeding problems, chronic blood clots, or people who have recently been involved in accidents that have caused bruising and bleeding should be excluded from treatment.

Another cause of adverse effects is the interaction of iboga or ibogaine with other drugs or pharmaceuticals. Before taking ibogaine, the recipient should avoid consuming drugs for a sufficient period to ensure that the drug has been eliminated. This depends on the half-life of the drug and is different for each substance. On the other hand, foods and substances that are metabolized by the enzyme CYP2D6 (an enzyme involved in the metabolism of many drugs) should be avoided, since they could interact with ibogaine, and potentiate its effects on bradycardia and QT prolongation. There are lists of such substances available on the Internet. Quinine and grapefruit belong to this group and should be avoided before and during treatment.

Given that iboga is offered in a variety of forms, taking a material whose chemical composition and potency are unknown is another risk factor. It is important to know the exact dose and composition of what is being consumed to avoid overdose or complications.


Although some centers accept people with psychiatric disorders such as bipolar, borderline personality disorder, etc. – and certain patients do report an improvement in their condition – nothing is known about the effects of ibogaine on such disorders or the risks that it involves. It is a dangerous landscape. In general, people with psychiatric disorders such as those mentioned above, as well as those suffering from schizophrenia and a history of psychosis, must be excluded from this treatment, since ibogaine could cause the reappearance or worsening of symptoms. Similarly, the interaction of ibogaine with certain psychotropic drugs can be dangerous. An in-depth psychiatric review as well as the supervision of a psychiatrist is important before engaging in treatment in case of the existence of a psychiatric disorder or the use of certain medications.

In addition to psychiatric risks, iboga and ibogaine are powerful psychoactive practices that can induce an introspective experience that is not always easy to manage. Episodes of extreme anxiety can occur, and in more serious cases, paranoia. A skilled facilitator should be able to offer necessary support to the individual and assist with difficult episodes. Proper preparation with the guidance of a therapist can help greatly in improving self-confidence, going into the experience with an appropriate mental state and being prepared for possible difficult experiences.


sustainabiliy concerns

biocultural sustainability

Bio-cultural sustainability of iboga is of great concern. Tabernanthe iboga has traditionally grown freely and abundantly in the forests of the Congo Basin and therefore communities have never needed to cultivate it. The Union for Conservation of Nature’s Red List of Threatened Species has listed Tabernanthe iboga as a plant of “least concern”, however not as endangered.

The major factors in­fluencing the regenerative capacity of iboga in the wild and its availability in urban areas are the extensive illegal harvesting for sale in international markets, the seizure of domes­tic shipments by police, and deforestation. Increased demand for iboga and ibogaine internationally is certainly having an impact and placing increased pressure on wild populations of the plants in Gabon.

Efforts to ensure sustainability for the plant include cultivation by traditional communities, agroforestry cultivation initiatives, pressure to stop iboga poaching from the wild, and developing pathways for implementation of the Nagoya Protocol, which would ensure access and benefit sharing.

As noted above, in February 2019, the Gabonese government halted all exports, stating concerns about the sustainability of the plant. They are developing mechanisms for export in line with the Nagoya Protocol. It is important that traditional communities have their voices heard on this issue and that they receive benefits from sharing iboga with the world.

An ideal future for iboga is one where iboga and the sacred practices that surround it contribute to the spiritual and economic emancipation of traditional communities in Gabon. This means building widespread recognition of the value of iboga, honouring the communities who have stewarded these teachings and practices, and supporting efforts to ensure traditions and knowledge are passed on from generation to generation.

NOTICE

attention:

Please remember that harm reduction strategies should always be implemented in conjunction with advice and support from healthcare professionals or other qualified experts. If you are seeking assistance for a specific medical or psychological condition, it is essential to consult with a licensed professional for personalized guidance.

Special Thanks to

psychonautwiki logo

Copyright © 2024 The Dope Doula - All Rights Reserved.

  • Services
  • OVERDOSE
  • Terms of Use
  • Privacy Policy
  • Artist Search Agreements

Powered by

We're Moving!


This website will close in a few days.
All harm reduction resources are systematically being added, and all updates will be available on Substack soon!

Thank you for being part of the journey — see you there!

Take me to the Stack

Let's get this over with...

We use cookies to analyze website traffic and provide an epic experience.  Since consent is a big deal, please be explicit:

🚫ᴅᴇᴄʟiɴᴇ✅ ᴄᴏɴꜱᴇɴᴛ